Utilizing your own bodies naturally occurring stem cells, we are able to harvest them, concentrate and deploy/inject them to areas of the body that require aggressive healing and repair. From neuro-degenerative disorders to joint pain and degenerative joint/spine diseases. Cell therapy is quickly gaining favor in research and treatment around the world. Specifically, we utilize stromal vascular fraction (SVF) for it's regenerative properties as outlined in this review paper published in US National Library of Medicine
National Institutes of Health
IRB Approved Neuro-Degenerative Disorders: I have divided them into two groups. Conditions we treat locally and those treated out of state by our affiliate cell surgical brain surgeon
Neuro/Brain disorders that are treatable in our Murray clinic.
- Multiple Sclerosis : The patient was diagnosed with relapsing-remitting MS in 1993, presenting symptoms were noticeable tingling and burning sensation in the right leg, followed by paraplegia lasting almost three weeks. Neurological investigations at the time uncovered MRI findings suggestive for a demyelinating syndrome. In June of 2008, the patient was treated with two I.V. infusions of 75 million autologous adipose-derived SVF cells... His gait, balance and coordination improved dramatically oven a period of several weeks. His condition continued to improve over the next few months and he is currently reporting a still continuing improvement and ability to jog, run and bike for extended periods of time daily.
- Parkinson's Disease:
Mesenchymal Stem cells(MSCs)Bone marrow, adipose tissue, umbilical cord, dermis, peripheral blood
1. Easily accessible source tissue 2. Rescue functional deficits in mice 3. Rare adverse effects in humans following transplantation 4. Considerable pluripotency
- Traumatic Brain Injury, Concussion, Head Trauma:
- This review discusses the most recent identification of MSC- and NPC-secreted factors, including those that are trafficked within extracellular membrane vesicles (EVs)
In direct contrast to other tissues in the mammalian body, the brain is unable to properly regenerate and reconnect the injured areas to the uninjured areas of the brain
- In the brain, Matsushita et al. reported that MSCs were able to cross the BBB through paracellular pathways
- Therefore, adult stem cells such as MSCs may be a good choice for stroke therapy because they secrete a variety of bioactive substances, including trophic factors and extracellular vesicles
Neuro/Brain disorders that require direct intraventricular brain injection by port by a brain surgeon
- ALS (Lou Gehrig's disease Disease)
- Alzheimer's Disease
- Systemic Lupus Erythematosus
- Multiple Sclerosis
- Crohn's Disease
- Irritable Bowel Disease
- Type 1 Diabetes
- Ankylosing Spondylitis
- Polymyalgia Rheumatica
- Rheumatoid Arthritis
- Sjögren's syndrome
- Thyroiditis, Hashimotos
Stromal vascular fraction (SVF) represents an attractive source of adult stem cells and progenitors, holding great promise for numerous cell therapy approaches. In 2017, it was reported that 1524 patients received autologous SVF following the enzymatic digestion of liposuction fat. The treatment was safe and effective and patients showed significant clinical improvement. In a collaborative study, we analyzed SVF obtained from 58 patients having degenerative, inflammatory, autoimmune diseases, and advanced stage cancer.
We found that a 2:1 ratio of ADSCs to HSC-progenitors seems to be the key for a successful cell therapy. These findings open the way to future rational design of new treatment regimens for individuals by adjusting the cell ratio before the treatment.
Inter-venous infusion using your own SVF/Stem Cells is proving to be a major victory in the battle to defeat this debilitating disease. Across the network we are seeing terrific results.
Inflammatory bowel disease
These results showed the potential advantage of freshly isolated autologous ADSCs in IBD patients
Osteoarthritis of the Spine, Discs and Related Injuries
Neck Arthritis and Spine disease have two common problems causing neck pain, degenerative disk disease and facet arthropathy (a type of arthritis) of the cervical spine. Not all disk problems are amenable to regenerative therapy and patient selection is very important to optimize outcomes. Many forms of spine pain are actually due to arthritis of the facet joints (small joints where vertebra connect to their adjacent neighboring vertebrae).
We have developed a Neck Arthritis and Spine disease protocol that attempts to exploit the anti-inflammatory and healing effects of SVF (rich in mesenchymal stem cells and growth factors). The protocol uses an advanced method of target planning using MRI with gadolinium contrast to identify inflamed or degenerated areas along the cervical spine. Once these are located, SVF is deployed by laser guided CAT scan to within 1mm of the targets seen on MRI. This is all done as an outpatient at the time of SVF harvesting and procurement. The entire procedure takes approximately 4 hours. This unique targeting and deployment system is the only one like it in the world for deploying SVF into backs.
Osteoarthritis of the Knee and Related Injuries
Knee arthritis is a form of degenerative joint disease that affects millions of Americans. There are several alternatives to knee surgery such as injection of cartilage substitutes or steroids. Steroid injection is not favored as a viable long term treatment since the steroids actually damage local tissues over time. Certain types of knee problems including significant meniscal and ligamentous injuries may not be amenable to regenerative therapy. It is important to evaluate each individual case to assess likelihood of success with attempting regenerative therapy. CSN has developed a degenerative knee disease protocol that attempts to exploit the anti-inflammatory and healing effects of SVF (rich in mesenchymal stem cells and growth factors). The protocol uses PRP autologous platelet rich plasma to optimize the effects of the SVF. The deployment protocol performed under local anesthesia is all done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately 3 hours.
Osteoarthritis of the Shoulder and Related Injuries
Shoulder problems come from chronic pain from rotator cuff injuries and arthritis of joints of the shoulder disables millions of Americans. Certain types of shoulder joint problems including certain tendon problems and ligamentous injuries may not be amenable to cell therapy. It is important to evaluate each individual case to assess likelihood of success with attempting regenerative therapy.
Osteoarthritis of the Hip and Related Injuries
Hip arthritis is a form of degenerative joint disease that affects millions of Americans. Patients try to delay hip replacement surgery for as long as possible and often seek hip injections with steroids. Steroid injection is not favored as a viable long term treatment since the steroids actually damage local tissues over time. Certain types of hip problems including certain fractures and injuries may not be amenable to cell therapy. It is important to evaluate each individual case to assess likelihood of success with attempting regenerative therapy. has developed a degenerative hip disease SVF deployment protocol that attempts to exploit the anti-inflammatory and healing effects of SVF (rich in mesenchymal stem cells and growth factors). SVF is injected using local anesthesia under radiographic guidance using CAT scanning to ensure that the injection is accurate. This is all done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately 3 hours.
As a common side effect of many systemic conditions and medications. Modern cell therapies are proving once again to be superior to other radical surgical implants or devices. We have partnered with one of the leading ED therapists in the US, Dr. Amy Killen, MD. She has personally mentored and trained our providers to use her method of treatment that enjoys a 90% success rate.